ResMed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 3,000 shares on the New York Stock Exchange for $812,310 in total, according to a Wednesday filing with the Australian bourse.
Following the sale of shares, Sandercock owns 146.4 million shares in the company, per the filing.